Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0002146784-26-000004

Corp. Controller & VP, Finance sold 1,224 shares at $10.29 ($12,595)

From the SEC's structured data for this filing

Trades in this filing

Tanini Annita · Corp. Controller & VP, Finance

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-18 Sale : show line 1 in the form −1,224 $10.29 $12,595 45,144 D
Open-market sales · 1,224 sh · avg $10.29 · $12,595
Loading xslF345X06/form4-08202026_040808.xml…